Dura and Spiros receive FDA review letter on Albuterol Spiros indicating need for additional study Nov. 9, 1998
Novel, noninvasive procedure cleared by FDA for debilitating sleep and breathing disorder Nov. 6, 1998
FR-110302 as clinical candidate for asthma, atherosclerosis and other inflammatory disorders Nov. 6, 1998
RSS